Download PDF

Michael Fadus

VP Compliance


• Compliance and ethics professional; qualified lawyer
• 20 years career experience in the US, Europe, Middle East & Africa, other emerging markets
• Compliance and risk focus in pharmaceutical, financial services, and automotive sectors
• Experience in Fortune Global 500, mid-sized, and start-up companies
• Headquarter, regional & field-based roles
• MBA, JD, MA, and BA degrees
• Admitted to practice law in California (1988)
• INSEAD Healthcare Compliance Leadership Program participant
• Six Sigma trained; PMP certified
• Dual US / Swiss citizen
• Native speaker of English, fluent in German
• High social intelligence


• Compliance leadership; coaching colleagues to make decisions about risk with confidence
• Anti-corruption programs: design, implementation, monitoring, and remediation
• Writing policies, procedures, sensitive reports, and audience-specific communications
• Training at all levels of the organization
• Engaging and communicating with relevant stakeholders, including court monitors
• Building, inspiring and managing teams across cultural and departmental borders
• Reducing costs and needless bureaucracy
• Driving ethical commercial success with practical but effective controls
• Adding value even in times of change


• Fulfilling requirements of corporate integrity agreements

• Monitoring requirements of deferred prosecution agreements

• Conducting investigations and drafting sensitive reports

• Third-party due diligence; business partner management

Work History and Key Accomplishments

Nov 2015Present

VP Compliance: Region Europe

Teva Pharmaceuticals

Implementing recent transformative change in compliance program, including massive restructuring and DPA Monitor review. Manage team of 20+ compliance officers throughout Europe.

Jun 2015Aug 2015

Compliance and Ethics Lead: CHAT, BeNeLux, Nordics

Bristol-Myers Squibb

Provided solutions to several long-standing, cross-functional compliance-related problems. Conducted initial inquiries into sensitive issues.

Nov 2013May 2015

Compliance Lead CEEMEA and Rare Diseases (ex-US)


Supported Shire affiliates and local operating companies outside of the US.Focused on enhancing the compliance program in the CEEMEA region and Rare Diseases business unit, and on implementing a global compliance risk assessment program. Traveled extensively to emerging markets.

Mar 2012Oct 2013

Compliance Consultant

MF Consulting

Key mandates included conducting a sustainability assessment at Daimler as part of a court-appointed team and designing an enhanced compliance program Sanofi-Aventis in Russia for application in other emerging market countries.

Nov 2009Nov 2011

Regional Compliance Director EEMEA


Directed a team of 13 full-time compliance professionals handling compliance in Eastern Europe, Middle East. after its acquisition of Schering-Plough.

Apr 2007Nov 2009

Regional Compliance Director CEE (and Western Europe)


Initially directed a team of 9 full-time and 5 part-time compliance professionals in Central and Eastern Europe and additionally Western Europe as of mid-2008 Schering-Pough was acquired in November 2009 by Merck & Co., Inc.

Nov 2005Mar 2007

Head of Group IT Communications

Zurich Insurance Company Ltd

Managed a team of 8 global specialists in print, electronic, and in-person communication activities for a function of 3, 500 IT staff supporting 100, 000+ employees and agents. Zurich is one of the world's leading insurance groups.

Mar 2004Oct 2005

HR Account Manager

Zurich Insurance Company Ltd

Recruited from compliance role to manage a team handling headquarter HR needs of the Group Finance Director and Chief Administrative Officer, including expatriate contracting matters. Zurich is one of the world's leading insurance groups.

Sep 2001Feb 2004

Compliance Officer

Zurich Insurance Company Ltd

Led divisional compliance officers to draft, publish, and implement the company's first anti-corruption policy. Zurich is one of the world's leading insurance groups,.

Sep 1996Nov 2000

General Counsel & VP of HR

American Payment Systems (now FiServ)

Hired as part of a select team charged with implementing sound financial, legal, HR, and compliance controls at American Payments Systems (APS), a leader of walk-in bill payment services. APS processed billions of dollars in bill payments annually through thousands of retail locations across the US. APS was ultimately acquired by FiServ.

Aug 1989Jul 1991

Associate Attorney

Lewis, D'Amato, Brisbois & Bisgaard

Researched issues and prepared legal documents as part of my formative legal experience after law school and a scholarship study in Germany. Founded in 1979, Lewis, D'Amato, Brisbois & Bisgaard became Lewis, Brisbois, Bisgaard & Smith.


Nov 2014Nov 2014

Healthcare Compliance Implementation Leadership Programme


Examples of Professional Activities

• For the Russian-speaking market, co-author with Alexander Tolmachev and Eduard Gyuloyan: "Non-
Promotional Communication in a Pharmaceutical Company", Remidium Journal, October 2013.

• Panelist: “Compliance: Necessary Evil or Good Business Practice?” at PwC’s annual BioBreakfast
Executive Workshop, November 8, 2011, Basel

• Webinar Panelist: “Is it Time for Policies to Dictate Social Media Participation?” at Pharma IQ’s Social
Media in Pharma Summit, July 26, 2011 at 16:15 CET

• Presenter: “Advanced Cultural Passport: Methods of Success Across National, Ethnic, and
Corporate Borders” at the Fourth International Pharmaceutical Regulatory and Compliance Congress,
May 17-19, 2010; Berlin

• Moderator: “Cooperation with Regulators” at the 2009 Annual Conference of the Association of
Corporate Counsel – Europe; June 7-9, 2009; Geneva

• Moderator and Presenter: “Managing Cultural Differences in Policy Harmonization” at the
Third International Pharmaceutical Regulatory and Compliance Congress, May 28-29, 2009; Rome

• Panelist: “Emerging Global Compliance Issues in North America, Europe, Middle East, Africa, and
Latin America” at the Second International Pharmaceutical Regulatory and Compliance Congress, May
28-29, 2008; Paris